ERBB2 and breast cancer: We generated HTICS by comparing gene expression profiles of enriched fractions of tumor initiating cells (TICs) versus non-TICs from mammary tumors isolated from a mouse model of HER2 breast cancer (MMTV-Her2/Neu) [23].